Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer - Top-Institutions - MDSpire

Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer

  • By

  • Giulia Sapuppo

  • Marco Russo

  • Grete Francesca Privitera

  • Michele Massimino

  • Sebastiano Piana

  • Maria Antonietta Trovato

  • Giusi Blanco

  • Davide Adinolfi

  • Giorgia Romano

  • Gabriella Pellegriti

  • June 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Kuma Hospital
    Kuma Hospital

    Kuma, Japan

    Key Differentiators

    • Thyroid Cancer
    • Surgery

  • #2

    Garibaldi-Nesima Medical Center
    Garibaldi-Nesima Medical Center

    Catania, Italy

    Key Differentiators

    • Endocrinology
    • Thyroid Cancer

  • #3

    Karolinska University Hospital
    Karolinska University Hospital

    Stockholm, Sweden

    Key Differentiators

    • Thyroid Cancer
    • Surgery

Original Source(s)

Disease site as an independent predictor of survival in radioiodine-refractory thyroid cancer

  • by Giulia Sapuppo, Marco Russo, Grete Francesca Privitera, Michele Massimino, Sebastiano Piana, Maria Antonietta Trovato, Giusi Blanco, Davide Adinolfi, Giorgia Romano, Gabriella Pellegriti

  • June 11, 2026

Related Content

Epigallocatechin-3-gallate suppressed breast oncogenesis via the miR-27a/Wnt/β-catenin pathway axis

Research progress on the etiology and pathogenesis of pancreatic cancer: a narrative review

Precision Diagnostics and the ADC Revolution

Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics

  • June 10, 2026

  • 15 min